Neuberger Berman Group »

Tscan Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $34k 18k 1.82
2025-06-30 $31k 21k 1.45

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Oracle Corp Common (ORCL)
Eli Lilly & Co Common (LLY)
Broadcom Common (AVGO)
Ishares Core S&p Etf Trust Etf-e Etf (IVV)
T Mobile Us Common (TMUS)
Berkshire Hathaway Inc Class B B Common (BRK.B)

View all positions for Neuberger Berman Group

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
BlackRock
Vanguard Group
Propel Bio Management
Standard Life Aberdeen
Deer Management
Alphabet
Simplify Asset Management
Morgan Stanley
Renaissance Technologies
DC Funds
Tang Capital Management
Geode Capital Management

View all funds holding Tscan Therapeutics